Government is struggling to tackle respiratory diseases is escalating the India bronchitis treatment market

Published: Mar 2021

India bronchitis treatment market is projected to grow at a significant CAGR of around 4.4% during the forecast period (2020-2026). There are several factors that are leading to the growth of the Indian bronchitis treatment market, which includes the rising cases for respiratory diseases, rising industrialization, and expansion of global market players in India. The Government of India is taking utmost steps to cater the rising cases of respiratory diseases, including pneumonia, asthma, bronchitis, and respiratory tract infections. The Indian Study on Epidemiology of Asthma, Respiratory Symptoms and Chronic Bronchitis in adults (INSEARCH) studies the asthma and other respiratory diseases in the country. 

Browse the full report description India Bronchitis Treatment Market Size, Share & Trends Analysis Report by Type (Drugs (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, and Others) and Oxygen Therapy) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/india-bronchitis-treatment-market

As per the Tobacco Atlas, every year, more than 932,600 Indians die due to tobacco-related diseases. Complacency in the face of the tobacco epidemic insulates the tobacco industry in India and ensures that tobacco's death toll will grow every year. Therefore, with the growth of the tobacco industry, backed by the change in lifestyle and dietary habits, will further augment the incidence rate of respiratory diseases in the country, which in turn, will lead to the growth of the bronchitis treatment market in India.

Market Coverage

Report Elements

Details

Study Period

2019-2026

Base year

2019

Forecast period

2020-2026

Segments Covered

By Technology

Key Companies Profiled

Abbott Laboratories, Bayer AG, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment dominates the market in base year?
  • Which segment will project fastest growth in the market during the forecast period?
  • How COVID-19 will impact the market growth in 2020 and coming years?

o Recovery Timeline

o Deviation from pre-COVID 

o Most affected segment

o Recommendations 

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

India Bronchitis Treatment Market – Segmentation

By Technology

  • Medication 

o Antibiotics

o Anti-inflammatory drugs

o Bronchodilators

o Others (Mucolytics) 

  • Oxygen Therapy

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/india-bronchitis-treatment-market